CareDx Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
CDNA$84.42+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share data)
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $82,197 | $89,921 |
| Marketable securities | 153,221 | 203,168 |
| Accounts receivable | 51,061 | 66,312 |
| Inventory | 19,471 | 19,232 |
| Prepaid and other current assets | 7,763 | 9,216 |
| Total current assets | 313,713 | 387,849 |
| Property and equipment, net | 35,246 | 35,529 |
| Operating leases right-of-use assets | 29,891 | 34,689 |
| Intangible assets, net | 45,701 | 43,051 |
| Goodwill | 40,336 | 37,523 |
| Restricted cash | 586 | 522 |
| Other assets | 1,353 | 3,828 |
| Total assets | $466,826 | $542,991 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,872 | $9,942 |
| Accrued compensation | 19,703 | 16,902 |
| Accrued and other liabilities | 45,497 | 49,131 |
| Total current liabilities | 78,072 | 75,975 |
| Deferred tax liability | 136 | — |
| Common stock warrant liability | — | 32 |
| Deferred payments for intangible assets | 2,461 | 2,418 |
| Operating lease liability, less current portion | 28,278 | 33,406 |
| Other liabilities | 96,551 | 249 |
| Total liabilities | 205,498 | 112,080 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock: $0.001 par value; 10,000,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022 | — | — |
| Common stock: $0.001 par value; 100,000,000 shares authorized at December 31, 2023 and 2022; 51,503,377 shares issued and outstanding at December 31, 2023; 53,583,301 shares issued and 53,533,250 shares outstanding at December 31, 2022 | 49 | 52 |
| Additional paid-in capital | 946,511 | 898,806 |
| Accumulated other comprehensive loss | (6,963) | (7,503) |
| Accumulated deficit | (678,269) | (460,444) |
| Total stockholders’ equity | 261,328 | 430,911 |
| Total liabilities and stockholders’ equity | $466,826 | $542,991 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.